Key Takeaways
-
Most Arizona DSO deals combine cash at close, rollover equity, and earnouts, and only the cash portion is guaranteed upfront.
-
Arizona’s corporate practice rules can allow non-dentist ownership, but buyers must register properly and structure MSAs carefully.
-
Valuations often fall in the 5x–9x EBITDA range, with higher multiples tied to scale, provider depth, payer mix, hygiene, and specialty.
-
Sellers can improve outcomes by negotiating clear earnout protections and treating rollover equity as a true investment decision.
-
McLerran & Associates represents only sellers and helps Arizona dentists run competitive processes to improve pricing and terms. Schedule a free, confidential discovery call today.
The Anatomy of a Typical Arizona DSO Deal
Most DSO transactions are structured across three components, each with different risk and liquidity profiles.
-
Cash at Close: The guaranteed, upfront portion of the purchase price that provides immediate liquidity.
-
Rollover Equity: A portion of the deal paid in stock of the acquiring DSO platform, which ties part of your outcome to the platform’s future performance.
-
Earnout: A contingent portion of the price paid over time, based on the practice meeting specific performance targets after closing.
These ranges come from current market data and serve as directional guides, not guarantees. The exact mix in any Arizona transaction can depend on practice size, specialty, buyer type, and negotiation strength. Only the cash-at-close portion is guaranteed at signing. Equity and earnouts carry more risk and a longer time horizon.
Rollover equity usually appears at two levels. Joint-venture (JV) equity often pays regular distributions and can create a higher floor but a lower ceiling. Holding-company equity usually does not pay distributions, yet it can create a higher upside if the platform sells at a premium multiple. Many dentists find it helpful to evaluate rollover equity the same way they would evaluate any other investment.
Arizona’s Legal Framework: Corporate Practice, MSA, and Registration
Arizona’s corporate practice of dentistry doctrine limits who can own or control a dental practice, yet the state allows more flexible structures than many others. Arizona law permits a business entity with non-dentist owners to own a dental practice if the entity registers with the Arizona State Board of Dental Examiners and names a licensed Arizona dentist responsible for clinical services at each office, per A.R.S. §§ 32-1262 and 32-1213.
This registration requirement has direct deal implications for Arizona dentists.
-
Registration is per office and triennial. Each branch location requires a separate application and fee, and registrations expire every 3 years, so an acquiring DSO must register each Arizona location and renew on a 3-year cycle.
-
Violations of Arizona’s business-entity registration rules can trigger civil penalties of up to $2,000 per violation, and the Board may refuse, suspend, or revoke a registration.
DSOs typically operate in Arizona through a Management Services Agreement (MSA). This long-term contract sits between the DSO’s management entity and a professional corporation (PC) owned by a licensed dentist. The PC earns and books clinical revenue, while the management services organization (MSO) charges the PC a management fee for administrative services such as revenue cycle, payroll, marketing, and facilities. The MSA defines those services and fees.
Fee-splitting prohibitions shape how that management fee works in Arizona. To comply with Arizona rules, MSA compensation must reflect bona fide management services at fair market value, rather than a disguised percentage of clinical professional fees. A cost-plus pricing method is widely viewed as defensible because it ties directly to the MSO’s documented cost of services and can be tested for fair market value.
For sellers, these legal requirements can influence which buyers qualify, how the deal entity is structured, and what representations and warranties the seller must sign. A DSO that lacks proper Arizona registration or uses a weak MSA structure can create post-close legal and regulatory risk that may reach back to the selling dentist.
Request a comprehensive, diligence-grade practice valuation from McLerran & Associates.
Valuation Multiples in Arizona: What Drives Your Number
DSO valuations for dental practices are usually expressed as a multiple of EBITDA, which means Earnings Before Interest, Taxes, Depreciation, and Amortization. EBITDA is a measure of operating profitability after normalizing for owner-specific expenses. The multiple applied to EBITDA produces the enterprise value.
Current market data points to directional ranges that can shift based on practice characteristics.
-
DSO valuations often land in a 5x to 9x EBITDA range. Practices with more than $1.5 million in collections, strong margins, modern technology, and a stable doctor team tend to sit toward the higher end. Specialty practices can exceed 10x EBITDA in competitive auctions.
-
Multi-location dental groups with $1 million to $3 million in adjusted EBITDA traded in a 6.5x to 9.0x band during 2024 through mid-2026.
-
Regional multi-site groups with $3 million to $10 million in adjusted EBITDA traded in an 8.0x to 11.0x band during the same period.
Several valuation drivers tend to work together and can move a practice toward the top or bottom of those ranges.
-
Revenue Scale and EBITDA Margin: EBITDA scale of $1 million to $5 million or more can add roughly 1x to 2x to the multiple. Larger practices often attract multiple letters of intent at once, which supports a true auction dynamic.
-
Provider Depth: Associate-led production, where the owner provides less than 70% of chair time, can add about 0.5x to 1.5x. Buyers see less key-person risk when production is spread across several providers.
-
Payer Mix: A commercial and PPO-heavy payer mix can add around 0.5x to the multiple, while heavy Medicaid or HMO concentration can compress it by 0.5x to 1.0x.
-
Hygiene Production: Hygiene revenue above 30% of collections often supports premium multiples and stronger DSO offers, adding about 0.5x to 1.0x.
-
Specialty: Orthodontics and oral and maxillofacial surgery practices traded at roughly a 1.0 to 3.0 turn premium to comparable-sized general practices on adjusted EBITDA during 2024 through mid-2026.
A CPA-led, diligence-grade EBITDA analysis can be critical for establishing a valuation that holds through buyer due diligence. McLerran & Associates builds valuations from the ground up, reviewing discretionary, personal, and non-recurring expenses so the number can withstand a buyer’s quality-of-earnings review.
Negotiating Cash at Close vs. Rollover Equity
Cash at close delivers immediate liquidity and carries no performance risk. Rollover equity can create meaningful upside, yet it remains illiquid until the DSO platform sells and its value depends on the platform’s financial health and future exit.
In many DSO transactions, cash at close falls in the 60% to 75% range of total consideration, with earnouts of 5% to 15% tied to retained EBITDA over 12 to 36 months. Pushing for a higher cash-at-close percentage can be one of the most effective negotiation levers for a seller, especially when multiple buyers compete for the practice.
Consider an anonymized example. A general dentist with a multi-provider practice received a single unsolicited offer with a relatively low cash-at-close component. After McLerran ran a structured, auction-style bid process that generated several competing offers, the seller secured a higher cash-at-close percentage on a higher headline price, which improved both immediate liquidity and total deal value.
Many sellers find it helpful to view rollover equity as an investment. Useful questions include whether the DSO platform is profitable at the practice level, whether revenue is growing at existing affiliated locations, how experienced the management team is, and whether the private equity backer has a strong capital base and a record of successful exits. McLerran evaluates buyers on these points and has blacklisted DSOs with consistently poor post-close environments.
Earnouts: How to Protect Your Payout
Earnouts can be the most risk-heavy part of a DSO deal for sellers. Across lower middle-market transactions, earnouts often pay only 40% to 60% of their stated headline value, so a $2 million earnout may yield $800,000 to $1.2 million in actual payments.
Common pitfalls include metric redefinition, post-close cost-cutting that suppresses EBITDA, and cliff-threshold structures where a small miss eliminates the entire earnout. Sliding-scale or dollar-for-dollar payout structures can reduce that risk and often serve sellers better than cliff thresholds.
Arizona sellers can focus on several key negotiation levers.
-
Pro-Rata Provisions: Structure the earnout so a near-miss on an EBITDA target still pays a proportional share instead of forfeiting the full amount.
-
Fixed Accounting Policies: Include fixed accounting policies and ordinary-course-of-business covenants to limit the buyer’s ability to change how EBITDA is calculated after closing.
-
Clear EBITDA Definitions: Spell out which expenses are included or excluded from EBITDA and who can approve post-close expenditures that affect that figure.
-
Termination Protections: Define what happens to earnout payments if the buyer terminates the employment agreement without cause before the earnout period ends.
Transition Employment and Non-Compete Terms
Most DSOs expect selling dentists to keep working at the practice for about 5 years after the sale. During this period, the seller moves from practice owner to W-2 employee and usually receives a market-rate clinical salary plus a production bonus. Post-close clinical compensation for a selling dentist often ranges from 25% to 32% of personal collections, which replaces owner distributions and can reduce annual income unless the terms are negotiated carefully.
Key employment terms include compensation structure, whether duties remain clinical-only or include management, benefits, and the ability to reduce chair time over the employment period. Dentists who already work fewer clinical hours may have more room to negotiate shorter work-back periods.
Non-compete clauses also deserve close attention. Many dental DSO non-competes start with broad geographic and time limits, and sellers can often negotiate narrower terms. Arizona courts require the geographic scope to match the area where the employer actually does business, and the restriction must relate to a legitimate interest such as trade secrets, confidential information, or patient goodwill. A 3-year term often serves as a seller-side benchmark, while 5 years is a common opening ask from buyers.
Real Estate and Other Practice Assets
Real estate usually sits outside the core practice valuation in a DSO transaction. Sellers can either include the property in the sale or keep ownership and lease it to the DSO.
Many DSOs will sign a long-term triple-net lease at a market cap rate, with 10 to 15-year terms, 2% to 3% annual rent escalations, and a required remaining term of 7 to 10 years plus renewal options.
Keeping the real estate and leasing it to the DSO can create a steady income stream after closing but also brings ongoing landlord responsibilities and ties the seller’s finances to the DSO’s continued occupancy. Selling the real estate provides immediate liquidity and removes those obligations. The better path can depend on the seller’s financial goals, tax profile, and appetite for ongoing involvement, and many dentists model both options before signing the letter of intent.
Other assets such as equipment, patient records, and goodwill typically transfer with the practice. A one-time sale of dental practice equipment in Arizona generally qualifies as a casual or occasional sale and escapes transaction privilege tax. Roughly 76% or more of the purchase price in a dental practice sale often allocates to goodwill for tax purposes, which is taxed at long-term capital gains rates instead of ordinary income rates.
Step-by-Step Process and Due Diligence
A typical McLerran-managed DSO transaction for an Arizona practice follows a clear sequence.
-
Discovery and Valuation: McLerran remotely accesses practice management software, pulls reports, and builds a CPA-led EBITDA analysis. The seller reviews the findings and approves the go-to-market plan.
-
Marketing and Bid Process: McLerran prepares a marketing deck and virtual data room, then solicits offers from a vetted buyer pool. The structured process usually runs 45 to 60 days and can generate around 10 offers.
-
LOI Negotiation: McLerran negotiates the letter of intent, including cash at close, equity structure, earnout terms, employment framework, and non-compete parameters, before the seller signs.
-
Due Diligence and Quality-of-Earnings Defense: The buyer’s team reviews financial, legal, and operational data. McLerran defends the EBITDA analysis and works to prevent re-trading.
-
Closing: Legal documents are finalized, Arizona Board registration requirements are confirmed for the acquiring entity, and the transaction closes.
The timeline from first conversation to wire transfer in a DSO transaction often runs 6 to 9 months. Many sellers find that having an advisor who controls and defends the EBITDA narrative from day one can be a central factor in whether the agreed value holds at closing.
Schedule a free, confidential discovery call with McLerran & Associates. Call (512) 900-7989 or email info@dentaltransitions.com.
The McLerran Advantage for Arizona Sellers
McLerran & Associates focuses exclusively on sell-side advisory for dental practice owners, including Arizona dentists considering a DSO affiliation. The Phoenix office, led by Brian Carroll, serves the Mountain West and connects local clients with the firm’s national buyer relationships.
The firm’s process rests on four coordinated pillars that work together from valuation through closing.
-
CPA-Led Valuation: Every engagement starts with a diligence-grade EBITDA analysis designed to withstand buyer scrutiny and avoid re-trading.
-
Competitive Auction Process: McLerran runs a structured bid process over roughly 45 to 60 days with a vetted pool of qualified buyers. Poorly run DSOs are excluded, and multiple offers help create real competition.
-
Multi-Structure Financial Forecasting: Sellers receive side-by-side modeling of cash, equity, and earnout outcomes over 3, 5, 7, and 10-year horizons, with a focus on after-tax proceeds rather than just headline prices.
-
Quality-of-Earnings Defense: McLerran stays engaged through diligence to defend the underwritten EBITDA when buyers push back, which can help preserve the agreed value.
These elements together have produced an approximately 85% to 90% transaction rate, compared with industry norms closer to 35% to 40%, and average valuations that sit about 30% higher than what many owners achieve when they sell on their own.
“My first interaction with McLerran was very positive. I called Brannon and he was not only very knowledgeable, [but] very empathetic to my needs… It was the best decision of my life.” — Dr. William Pena, American Pediatric Dental Group (DSO affiliation resulting in a valuation approximately 20% higher than offers already on the table)
“They didn’t bias me one way or another. They let me choose, but they answered all my questions every step along the way. So I felt like I was an informed consumer.” — Dr. Mark Sweeney, Austin Dental Spa (DSO transaction, 40+ years in practice)
Frequently Asked Questions
How Much Cash Can I Expect at Close in an Arizona DSO Deal?
Cash at close in a DSO transaction typically represents the majority of the headline purchase price, with the remainder in rollover equity and earnout. The 60% to 75% range discussed earlier can shift based on practice size, specialty, buyer type, and negotiation strength. Larger practices with stronger EBITDA and several competing buyers often secure higher cash-at-close percentages. A diligence-grade valuation and a competitive process can provide the clearest picture of what your specific practice can support.
Can I Sell My Dental Practice to a DSO in Arizona?
Yes. Arizona’s legal framework is more permissive than many states for DSO ownership structures. A business entity with non-dentist owners can own a dental practice if it registers with the Arizona State Board of Dental Examiners and names a licensed Arizona dentist responsible for clinical services at each office. DSOs usually operate through an MSA with a dentist-owned professional corporation. Sellers can protect themselves by confirming that any buyer is properly registered in Arizona and that the MSA complies with the state’s fee-splitting rules.
What Is a Management Services Agreement (MSA)?
A Management Services Agreement is the contract that defines the relationship between a DSO’s management entity and the dentist-owned professional corporation that holds the clinical license. The MSA lists the non-clinical services the DSO provides, such as billing, HR, marketing, facilities management, and IT, and it sets the management fee the professional corporation pays. In Arizona, that fee must reflect bona fide services at fair market value rather than a percentage of clinical professional fees to comply with fee-splitting rules. MSAs are typically long-term agreements, often 20 to 40 years, and their terms can shape the seller’s post-close obligations and the DSO’s operational control.
Do I Have to Keep Working After I Sell to a DSO?
In virtually all DSO transactions, a post-close employment period of about 5 years is standard. During this time, the selling dentist works as a W-2 employee with a market-rate clinical salary and production bonus. This shift replaces owner distributions with employment income and can reduce annual earnings unless the employment terms are negotiated carefully. Dentists who already work fewer clinical hours may be able to negotiate shorter work-back periods. The employment agreement should clearly define compensation, clinical duties, non-compete scope, and what happens to earnout and equity if the buyer terminates the agreement without cause.
How Do I Know If a DSO Is a Good Partner?
DSOs vary widely in quality, culture, and financial strength. Helpful questions include whether the platform is profitable at the practice level, whether revenue is growing at existing affiliated locations, whether the management team has a record of successful integrations, and whether the private equity backer is financially strong with experience in dental. Feedback from dentists who already affiliated with the DSO can also be revealing. McLerran & Associates vets buyers on these dimensions before they enter a process and has blacklisted DSOs known for weak post-close environments, including some that emerged when capital rapidly entered the space. Many sellers view this buyer-level insight as an important layer of protection.
